Xenetic Biosciences, Inc.

NasdaqCM:XBIO 株式レポート

時価総額:US$6.3m

Xenetic Biosciences マネジメント

マネジメント 基準チェック /34

現在、CEO に関する十分な情報がありません。

主要情報

Jim Parslow

最高経営責任者

US$433.7k

報酬総額

CEO給与比率75.9%
CEO在任期間7.6yrs
CEOの所有権n/a
経営陣の平均在職期間データなし
取締役会の平均在任期間5.3yrs

経営陣の近況

Most Shareholders Will Probably Find That The Compensation For Xenetic Biosciences, Inc.'s (NASDAQ:XBIO) CEO Is Reasonable

Dec 15
Most Shareholders Will Probably Find That The Compensation For Xenetic Biosciences, Inc.'s (NASDAQ:XBIO) CEO Is Reasonable

Why We Think Xenetic Biosciences, Inc.'s (NASDAQ:XBIO) CEO Compensation Is Not Excessive At All

Dec 01
Why We Think Xenetic Biosciences, Inc.'s (NASDAQ:XBIO) CEO Compensation Is Not Excessive At All

Recent updates

Most Shareholders Will Probably Find That The Compensation For Xenetic Biosciences, Inc.'s (NASDAQ:XBIO) CEO Is Reasonable

Dec 15
Most Shareholders Will Probably Find That The Compensation For Xenetic Biosciences, Inc.'s (NASDAQ:XBIO) CEO Is Reasonable

Why We Think Xenetic Biosciences, Inc.'s (NASDAQ:XBIO) CEO Compensation Is Not Excessive At All

Dec 01
Why We Think Xenetic Biosciences, Inc.'s (NASDAQ:XBIO) CEO Compensation Is Not Excessive At All

Xenetic Biosciences reports Q2 results

Aug 12

Xenetic Biosciences, VolitionRx collaborate to develop cell therapies to treat cancer

Aug 02

Xenetic inks clinical manufacturing contract with Catalent

Jul 07

Xenetic Biosciences reports Q3 results

Nov 13

CEO報酬分析

Xenetic Biosciences の収益と比較して、Jim Parslow の報酬はどのように変化したか?
日付総報酬給与会社業績
Sep 30 2024n/an/a

-US$4m

Jun 30 2024n/an/a

-US$5m

Mar 31 2024n/an/a

-US$4m

Dec 31 2023US$434kUS$329k

-US$4m

Sep 30 2023n/an/a

-US$4m

Jun 30 2023n/an/a

-US$4m

Mar 31 2023n/an/a

-US$6m

Dec 31 2022US$474kUS$329k

-US$7m

Sep 30 2022n/an/a

-US$7m

Jun 30 2022n/an/a

-US$7m

Mar 31 2022n/an/a

-US$6m

Dec 31 2021US$521kUS$299k

-US$6m

Sep 30 2021n/an/a

-US$5m

Jun 30 2021n/an/a

-US$11m

Mar 31 2021n/an/a

-US$11m

Dec 31 2020US$359kUS$285k

-US$11m

Sep 30 2020n/an/a

-US$11m

Jun 30 2020n/an/a

-US$14m

Mar 31 2020n/an/a

-US$14m

Dec 31 2019US$388kUS$265k

-US$18m

Sep 30 2019n/an/a

-US$19m

Jun 30 2019n/an/a

-US$10m

Mar 31 2019n/an/a

-US$11m

Dec 31 2018US$288kUS$265k

-US$7m

Sep 30 2018n/an/a

-US$1m

Jun 30 2018n/an/a

-US$2m

Mar 31 2018n/an/a

-US$3m

Dec 31 2017US$960kUS$199k

-US$4m

報酬と市場: Jimの 総報酬 ($USD 433.73K ) は、 US市場 ($USD 650.80K ) の同様の規模の企業の平均を下回っています。

報酬と収益: Jimの報酬は、過去 1 年間の会社の業績と一致しています。


CEO(最高経営責任者

Jim Parslow (59 yo)

7.6yrs

在職期間

US$433,732

報酬

Mr. James F. Parslow, also known as Jim, has been Chief Financial Officer at Xenetic Biosciences, Inc. since April 03, 2017 and serves as its Chief Operating Officer and Corporate Secretary and serves as i...


取締役

名称ポジション在職期間報酬所有権
Jeffrey Eisenberg
President & Director8.3yrsUS$563.49k0.027%
$ 1.7k
Moshe Mizrahy
Independent Non Executive Directorless than a yearUS$12.33k0%
$ 0
Roger Kornberg
Independent Director8.8yrsUS$57.54k0%
$ 0
Firdaus Dastoor
Independent Director10.8yrsUS$57.54k0%
$ 0
Dmitry Genkin
Non-Executive Directorless than a yearデータなし4.44%
$ 281.0k
Guenther Koehne
Member of Scientific Advisory Board5.5yrsデータなしデータなし
Matthew Frigault
Member of Scientific Advisory Board5.8yrsデータなしデータなし
Alexey Vinogradov
Independent Director5.3yrsUS$57.54kデータなし
Grigory Borisenko
Independent Non-Executive Director5.2yrsUS$57.54k0%
$ 0
Maksim Mamonkin
Member of Scientific Advisory Board4.8yrsデータなしデータなし
Allan Tsung
Member of Scientific Advisory Board2.5yrsデータなしデータなし
Jonathan Spicer
Member of Scientific Advisory Board2yrsデータなしデータなし

5.3yrs

平均在職期間

58yo

平均年齢

経験豊富なボード: XBIOの 取締役会経験豊富 であると考えられます ( 5.3年の平均在任期間)。